#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16884	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2233	750.5	0	.	n	.	0	C451T	SNP	451	451	C	682	682	T	1006	T,C	479,466	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16884	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2233	750.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	1010	C,T	949,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30578	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3609	843.9	0	.	n	.	0	T695C	SNP	695	695	T	997	997	C	890	C,T,A	837,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30578	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3609	843.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2273	2273	C	957	C,T	890,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30578	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3609	843.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2347	2347	A	959	A	905	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30578	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3609	843.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2899	2899	C	967	C	921	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2496	folP	855	855	100.0	folP.l15.c4.ctg.1	1549	159.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1085	1087	AGC	270;267;270	A;G;C,T	248;248;246,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6776	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3287	204.9	1	SNP	p	S91F	1	.	.	271	273	TTC	550	552	TTC	235;235;234	T;T;C	222;221;221	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6776	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3287	204.9	1	SNP	p	D95G	1	.	.	283	285	GGC	562	564	GGC	230;227;227	G;G;C	219;213;215	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6776	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3287	204.9	1	SNP	p	G95N	0	.	.	283	285	GGC	562	564	GGC	230;227;227	G;G;C	219;213;215	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2040	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1411	144.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	518	520	ACC	237;238;235	A,C;C;C	204,1;219;218	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2040	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1411	144.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	533	535	CAC	228;230;231	C;A;C	203;201;212	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2040	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1411	144.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	716	718	CAC	281;282;285	C;A;C	258;259;265	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	2040	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1411	144.3	1	SNP	p	G45D	0	.	.	133	135	GGC	536	538	GGC	232;233;234	G;G;C	210;206;214	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1156	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1149	100.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5796	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2935	196.8	1	SNP	p	D86N	0	.	.	256	258	GAC	511	513	GAC	200;201;203	G;A;C	186;185;190	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5796	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2935	196.8	1	SNP	p	R87W	0	.	.	259	261	CGT	514	516	CGT	201;197;201	C;G;T	191;186;187	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5796	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2935	196.8	1	SNP	p	R87I	0	.	.	259	261	CGT	514	516	CGT	201;197;201	C;G;T	191;186;187	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5796	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2935	196.8	1	SNP	p	S87R	1	.	.	259	261	CGT	514	516	CGT	201;197;201	C;G;T	191;186;187	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5796	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2935	196.8	1	SNP	p	S88P	0	.	.	262	264	TCC	517	519	TCC	203;205;207	T;C;C	195;195;195	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5030	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2598	192.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1570	1572	GGC	259;255;254	G;G;C	241;238;235	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1297	1299	GCC	285;289;290	G;C;C	265;268;269	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1300	1302	ATG	291;291;290	A;T;G	273;272;268	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1312	1314	ACC	274;273;274	A;C;C	258;256;258	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1312	1314	ACC	274;273;274	A;C;C	258;256;258	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1813	1815	ACC	269;271;272	A;C;C	244;249;250	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1867	1869	GCG	274;276;278	G;C;G	261;263;264	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1867	1869	GCG	274;276;278	G;C;G	261;263;264	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1990	1992	GGT	205;202;204	G;G,T;T	185;182,1;182	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1999	2001	AGC	197;197;196	A,G;G;C	179,1;178;181	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4806	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2384	200.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2017	2019	CCG	158;161;158	C,G;C;G	136,1;139;135	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6862	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3062	223.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1600	1602	CCG	259;260;258	C;C;G,A	235;240;234,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2704	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1970	136.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	503	503	C	167	C	154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3362	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1631	204.4	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1011	1013	AGA	277;278;277	A;G,A;A	263;264,1;263	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3362	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1631	204.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1032	1034	GGT	263;264;266	G;G;T	255;256;257	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3362	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1631	204.4	1	SNP	p	G120K	1	.	.	358	360	AAG	741	743	AAG	285;286;286	A,G;A,G;G,C	266,1;270,1;263,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3362	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1631	204.4	1	SNP	p	A121N	1	.	.	361	363	AAC	744	746	AAC	285;289;291	A;A,G;C	267;270,1;268	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3362	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1631	204.4	1	SNP	p	N121D	0	.	.	361	363	AAC	744	746	AAC	285;289;291	A;A,G;C	267;270,1;268	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12036	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4894	245.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1274	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	892	140.4	1	SNP	p	V57M	1	.	.	169	171	ATG	458	460	ATG	276;280;281	A;T;G	264;266;265	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
